• Status and Expenses- Re-Use Of Insulin Syringe Needles in the Diabetic Patients in Beijing

    Nov 1, 2016, 00:00

  • Utilisation of Antiretrovirals in the Slovak Republic - A 10-Year Retrospective Study

    Nov 1, 2016, 00:00

  • Societal Impact of Pain (SIP) 2016 - 8 Policy Recommendations- Time for Action

    Nov 1, 2016, 00:00

  • Hospitalization Cost and Length of Stay Associated with HPV-Related Diseases

    Nov 1, 2016, 00:00

  • Time to Diabetes Related Complications for Newly Diagnosed Diabetes Patients in Singapore

    Nov 1, 2016, 00:00

  • The Application of Population Models to Improve Access to Medical Innovations and Population Health – A Systematic Review

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of A Potential Treatment Introduction for Anorexia-Cachexia in Non-Small Cell Lung Cancer Patients

    Nov 1, 2016, 00:00

  • The Burden of Illness of Mycosis Fungoides Cutaneous T-Cell Lymphoma- A Retrospective Cohort Study of a Commercially Insured Population in the U.S

    Nov 1, 2016, 00:00

  • The Benefits of Earlier Treatment with Paritaprevir/Rotanavir/Ombitasvir with or without Dasabuvir in Ireland

    Nov 1, 2016, 00:00

  • The Use of Consensus Techniques to Inform Health Technology Appraisals

    Nov 1, 2016, 00:00

  • Cost Effectiveness of Sacubitril/Valsartan Versus Angiotensin-Converting-Enzyme Inhibitor For The Treatment of Heart Failure From Public Health Perspective in Chile

    Nov 1, 2016, 00:00

  • Extra Budgetary Reimbursement Options For Innovations In The German Hospital Sector

    Nov 1, 2016, 00:00

  • Comparison of Bayesian Network Meta-Analyses in a Winbugs and SAS Framework

    Nov 1, 2016, 00:00

  • The Situate Detection System - A Cost-Effective Approach to Preventing Retained Surgical Sponges

    Nov 1, 2016, 00:00

  • Recommended vs Reimbursed vs Actually used Chemiotherapeutics in Pancreatic Adenocarcinoma in Poland

    Nov 1, 2016, 00:00

  • Clinical and Economic Impact of Blood Cultures Among Adult Patients Admitted with Pneumonia in Tianjin, China

    Nov 1, 2016, 00:00

  • What Is The Hospital Economic Burden Of Hiv In France? Results from an analysis of the national french medical information system database

    Nov 1, 2016, 00:00

  • Adherence To Treatment And Modifiable Risk Factors In Acute Coronary Syndrome (Acs) Patients Registered In The Pgrx Real World Datasets

    Nov 1, 2016, 00:00

  • High-Sensitivity C-Reactive Protein Measurements in Patients with a History of Myocardial Infarction- A Targeted Literature Review

    Nov 1, 2016, 00:00

  • Use of Sutureless Prosthesis Neutralizes Expected Worse Economic Impact of High Risk Patients Undergoing Aortic Valve Replacement

    Nov 1, 2016, 00:00

  • Determinants of The Impact of The Economic Crisis on General and Oral Health in Greater Athens Area Greece

    Nov 1, 2016, 00:00

  • The Clinical And Pharmacoeconomic Value of Febuxostat For The Treatment of Persistent Hyperuricaemia- A Systematic Literature Review

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Sacubitril/Valsartan in Chronic Heart Failure with Reduced Ejection Fraction in Spain

    Nov 1, 2016, 00:00

  • A Systematic Literature Review of Cysteamine Bitartrate Preparations in Patients with Cystinosis

    Nov 1, 2016, 00:00

  • Assessing The Cost-Effectiveness of Secukinumab Compared To Tnf Inhibitors As Second Line Biologic Treatment In Psoriatic Arthritis

    Nov 1, 2016, 00:00

  • Asthma in Fran Analysis of 2015 National Health and Wellness Survey Data

    Nov 1, 2016, 00:00

  • A Barriers to and Facilitators of the use of HTA Reports by Policymakers in Kazakhstan

    Nov 1, 2016, 00:00

  • Analysis of The Costs Associated with Vitamin K Antagonist Treatment for Stroke Prevention in Non Valvular Atrial Fibrialltion in Russia

    Nov 1, 2016, 00:00

  • The Dynamics of Quality of Life In Children With Uncontrolled Severe Persistent Asthma

    Nov 1, 2016, 00:00

  • Can Pharmaceutical Care Intervention Improve Lipid Profile in Type 2 Diabetes Patients; A Prospective Intervention Study in a Tertiary Hospital in Nigeria

    Nov 1, 2016, 00:00

  • Real World Tolerability And Effectiveness of Exenatide Once-Weekly Compared To Basal Insulin Among Elderly Patients with Type 2 Diabetes (T2D)

    Nov 1, 2016, 00:00

  • Quality Of Life and Economic Impact Of Neuropathic Pain and Fibromyalgia Syndrome In Chronic Back Pain Patients In Tertiary Care

    Nov 1, 2016, 00:00

  • A Conceptual Framework of Baseline Equity for Rural Basic Medical Insurance in China- Based on Policy Process Theory

    Nov 1, 2016, 00:00

  • Assessing Statin-Associated Myopathy using Administrative Data from a German Health Insurance Fund- Results of a Pilot Study

    Nov 1, 2016, 00:00

  • Assessment of Knowledge and Perception Regarding Breast Cancer Among Patients Attending Gynecological Department of Tertiary Care Hospital in Quetta Pakistan

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Ixekizumab vs. Secukinumab in Sequential Biologic Treatment of Psoriasis in the UK

    Nov 1, 2016, 00:00

  • Acceptability of Electronic Patient Reported Outcomes In Clinical Care of HIV

    Nov 1, 2016, 00:00

  • Factors Associated with Glycemic Control and Diabetes-Related Costs in Patients with Diabetes in the United Arab Emirates- Results From A Retrospective Large Claims Data Analysis

    Nov 1, 2016, 00:00

  • Management of Soft Tissue Sarcoma in France - A Retrospective Analysis of The French Clinical Biological Sarcoma Database (CONTICANET)

    Nov 1, 2016, 00:00

  • The Role of Weight Loss or Gain In Payer Assessment of Diabetes Drugs

    Nov 1, 2016, 00:00

  • A Network Metanalysis To Compare Biologic Agents In The Treatment of Non-Radiographic Axial Spondyloarthritis

    Nov 1, 2016, 00:00

  • Life Expectancy, Quality-Adjusted Life Years, and Total Lifetime Costs for Australian People with Multiple Sclerosis

    Nov 1, 2016, 00:00

  • Effect of Clinical Pharmacist in Patient Safety-A Prospective Interventional Study

    Nov 1, 2016, 00:00

  • Health Care Costs Among COPD Patients Are Doubled Compared to A Control Population

    Nov 1, 2016, 00:00

  • Healthcare Resource Use Alongside Novel Treatments for Advanced Melanoma in the Netherlands

    Nov 1, 2016, 00:00

  • The Cost Of Illness of Ultra-Rare Cryopyrin Associated Periodic Syndromes (CAPS) In Italy- Preliminary Results From The Radicea Project

    Nov 1, 2016, 00:00

  • Multiple Myeloma and Health-Related Quality of Life from EQ-5D and EORTC- A Systematic Literature Review

    Nov 1, 2016, 00:00

  • Comparison of the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (Esmo-Mcsb) and the American Society of Clinical Oncology (Asco) Framework for Assessing Value in Cancer Care

    Nov 1, 2016, 00:00

  • A Patient Survey Regarding Risk of Opioid Abuse- Results of A Pilot Study

    Nov 1, 2016, 00:00

  • Costs and Benefits of Home Food Industry Issuance Program in Indonesia

    Nov 1, 2016, 00:00

  • Willingness To Pay For Primary Dysmenorrhea Health States

    Nov 1, 2016, 00:00

  • Treatment Gap of Post Osteoporotic Fractures in Taiwan- A Nationwide Cohort Study, 2008-2013

    Nov 1, 2016, 00:00

  • Cost Effectiveness Analysis of A Flash Glucose Monitoring System for Type 2 Diabetes (T2DM) Patients Receiving Intensive Insulin Treatment in Europe

    Nov 1, 2016, 00:00

  • A Review of Assessments of The Quality of Pharmacoeconomic Evaluations in China

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Tiotropium Versus Glycopyrronium In Moderate To Very Severe COPD In France

    Nov 1, 2016, 00:00

  • Antimicrobial Agents Dispensing In Upper Respiratory Tract, Gastrointestinal Tract Infections And Infected Wound In Thai Drug Stores In 2015

    Nov 1, 2016, 00:00

  • EFFECTIVENESS OF THE TRX SUSPENSION TRAINER IN PEOPLE WITH OSTEOARTHRITIS

    Nov 1, 2016, 00:00

  • Health Economic Evaluation of Hydrophilic Coated Versus Non-Coated Urinary Catheters for Intermittent Use in Japan

    Nov 1, 2016, 00:00

  • Cost of Ebola Virus Disease Diagnosis Using Rapid Point-Of-Care Diagnostics in Sierra Leone

    Nov 1, 2016, 00:00

  • Healthcare Costs of Inflammatory Bowel Disease in The Biologic Era- A Study Of 2,451 Patients with Twelve years Follow-Up Evaluation

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Lipegfilgrastim in Prophylaxis of Febrile Neutropenia in Cancer Patients

    Nov 1, 2016, 00:00

  • Costs Associated with Treatment Induced Peripheral Neuropathy in Patients with Multiple Myeloma (MM)

    Nov 1, 2016, 00:00

  • Medication Cost Of Acute Myeloid Leukemia- A Descriptive Study

    Nov 1, 2016, 00:00

  • Longitudinal Trajectories of Depressive and Anxious Symptoms Following a Self-Management Intervention for Haemodialysis Patients

    Nov 1, 2016, 00:00

  • Comorbidities in HIV-1- A Literature Review of the Associations Between Patient- and Disease-Related Factors and Non-Aids Related Comorbidities (NARCS)

    Nov 1, 2016, 00:00

  • Treatment Patterns of Rheumatoid Arthritis in Japanese Hospitals and Predictors of Initiation Biologic Agents

    Nov 1, 2016, 00:00

  • The Health Economics Analysis of Unqualified Venous Blood Samples In The Chinese Tertiary Referral Hospital

    Nov 1, 2016, 00:00

  • Estimating The Economic and Clinical Benefits of Mirabegron Versus Antimuscarinics for The Treatment of Overactive Bladder (OAB) in The United Kingdom (UK)

    Nov 1, 2016, 00:00

  • Comparison of Informal Caregiving Time Required by Alzheimer's Disease Patients and Mild Cognitive Impairment Patients

    Nov 1, 2016, 00:00

  • A Study on Identification, Monitoring and Management of Adverse Drug Reactions in a Tertiary Care Hospital

    Nov 1, 2016, 00:00

  • Predictors of First Line Treatment Persistence Among Patients with Metastatic Renal Cell Carcinoma in The United States, Western Europe, and Japan

    Nov 1, 2016, 00:00

  • Costs And Quality of Life of Low Back Pain- A Multi-Register Based National Treatment Pathway Model In Sweden

    Nov 1, 2016, 00:00

  • Using Orthogonal Design in Selecting Health States for the Construction of EQ-5D-3L Value Set

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of H. Pylori Eradication Treatment Regimens in Peptic Ulcer Disease in Ukraine

    Nov 1, 2016, 00:00

  • Two-Year Antecedent Versus Subsequent Diagnoses of Patients Newly Diagnosed with Primary Restless Legs Syndrome- A Large-Scale Retrospective Claims Analysis

    Nov 1, 2016, 00:00

  • Societal Implications of Medical Insurance Coverage for Imatinib as First-Line Treatment of Chronic Myeloid Leukaemia in China- A Cost Effectiveness Analysis

    Nov 1, 2016, 00:00

  • Investigating Performance Indicators and Service Quality Improvement in an Outpatient Cardiology Department

    Nov 1, 2016, 00:00

  • Castration-Resistant Prostate Cancer (CRPC)- Evaluation of The Quality of Care and Disease Management in Real-Life Setting

    Nov 1, 2016, 00:00

  • A Retrospective Analysis of Heart Failure Prescription Adherence and the Hospitalization Outcome- A Tertiary Medical Center Experience in Taiwan

    Nov 1, 2016, 00:00

  • Adherence to Osteoporosis Drugs and Clinical Outcomes Among Osteoporosis Patients with Different Risk Profiles

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Continuous Intraduodenal Levodopa Intestinal Gel Infusion in the Treatment of Advanced and Severe Forms of Parkinson's Disease

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Caspofungin Versus Voriconazole in the Empirical Antifungal Therapy of Febrile Neutropenia in China

    Nov 1, 2016, 00:00

  • Ethical Standards In Reporting Research From Retrospective Observational Studies Based On Databases Using Anonymous And Personally Unidentifiable

    Nov 1, 2016, 00:00

  • Health Technology Assessment in Argentina- At what Point in the Life-Cycle of Technologies are they Requested

    Nov 1, 2016, 00:00

  • Comparative Analysis Of Medication Possession Ratio Measures For Adherence To Single-Medication

    Nov 1, 2016, 00:00

  • Economic Impact of Macular Edema Diseases in Italy

    Nov 1, 2016, 00:00

  • Perliminary Study of Medication Regimen Complexity Among Taiwanese Elderly who Have Used Anxiety or Hypnotics Prescriptions

    Nov 1, 2016, 00:00

  • Willingness to Pay For A Quality-Adjusted Life Year of Outpatients with Cardiovascular Diseases

    Nov 1, 2016, 00:00

  • Developing HTA Guidelines for Rare Disease Therapies - an Industry Perspective

    Nov 1, 2016, 00:00

  • The Economic Burden of Multiple Sclerosis in Spain- A Population Based Study

    Nov 1, 2016, 00:00

  • Rheumatoid Arthritis- Treatment Sequencing in Guidelines Compared to Real-World Evidence. A German Claims Data Analysis

    Nov 1, 2016, 00:00

  • Cost Minimisation Analysis Of Follitropin Delta Versus Follitropin Alfa In Assisted Reproductive Technologies (Ivf/Icsi) In The United Kingdom

    Nov 1, 2016, 00:00

  • Predicting Orphan Designation And Marketing Authorisation Based On A Review Of The European Medicines Agency Orphan Disease Register

    Nov 1, 2016, 00:00

  • A New Organizational Integrated Home-Care Model- An Italian Pilot Study

    Nov 1, 2016, 00:00

  • Need of Cosmetovigilance in India

    Nov 1, 2016, 00:00

  • Getting Medical Innovation to Patients in Developing Countries - A Systemic Approach to Setting Price and Access

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Rotavirus Vaccination in Hangzhou, China- A Comparison Between two Vaccines

    Nov 1, 2016, 00:00

  • Knowledge, Attitude and Practice (KAP) Regarding Blood Donation Among Health Care Workers in Malaysia

    Nov 1, 2016, 00:00

  • Effectiveness And Cost-Effectiveness of The Salut Programme – A Universal Health Promotion Intervention For Parents And Children

    Nov 1, 2016, 00:00

  • Detection and Analysis of Therapy Lines and Other Event Sequences in Claims Data

    Nov 1, 2016, 00:00

  • Evaluation Of The Value Of Pharmaceutical Products In Taiwan

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Cancer Risk Reduction Strategies for BRCA Mutation Carriers

    Nov 1, 2016, 00:00

  • Subject Recommendations for Improving Their Compliance in Completing Electronic Diaries in Depression Clinical Trials

    Nov 1, 2016, 00:00

  • Well-Being- What Is It, How Does it Compare to Health and What are the Implications of Using it to Inform Health Policy?

    Nov 1, 2016, 00:00

  • Economic Burden of Maintaining Vascular Access Patency in Patients with Hemodialysis Fistulas - A National Population-Based Study

    Nov 1, 2016, 00:00

  • Patient Characteristics and Clinical Outcomes of Patients with Liver Cancer in a Tertiary-Care Hospital in Malaysia

    Nov 1, 2016, 00:00

  • Budget-Impact Analysis (Bia) Of The Introduction Of 52mg Levonorgestrel-Releasing Intrauterine System (Lng-Ius) As A Contraceptive Method Option In The Brazilian Public Healthcare System (Sus) To Avoid Unintended Pregnancy (Up) In 15 To 19 ...

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Of Acupuncture Treatment In Mental Disorder- A Systematic Review

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Nivolumab for the Treatment Of Advanced Non-Squamous Non-Small Cell Lung Cancer (Nsclc) In Saudi Arabia

    Nov 1, 2016, 00:00

  • Correlation Between Structural Damage and Work/Activity Impairment Among Rheumatoid Arthritis Patients

    Nov 1, 2016, 00:00

  • Issues Related to the Frequency of Exploratory Analyses by Evidence Review Groups in the Nice Single Technology Appraisal Process

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Sunitinib Versus Best Supportive Care for The Treatment of Metastatic Renal Cell Carcinoma in Chile

    Nov 1, 2016, 00:00

  • Autoinjector Preference Among Patients with Multiple Sclerosis- Results From A National Survey

    Nov 1, 2016, 00:00

  • Possible Explanations as to Why Effective Products Still Don't Have a Price in France

    Nov 1, 2016, 00:00

  • Comparative Efficacy of Daratumumab Monotherapy and Pomalidomide Plus Low Dose Dexamethasone (POMA+LODEX) in The Treatment of Multiple Myeloma - A Matching Adjusted Indirect Comparison (MAIC)

    Nov 1, 2016, 00:00

  • The Impact of Dementia on the Outcomes of Treatments For Acute Coronary Syndrome

    Nov 1, 2016, 00:00

  • Informal Care and Productivity Losses are Important in Advanced Cutaneous Melanoma- Results of the Dutch Melanoma Treatment Registry

    Nov 1, 2016, 00:00

  • An Assessment Of Biosimilars’ Behaviour In The Eu-5 Countries

    Nov 1, 2016, 00:00

  • Exploring Bias in Meta-Analysis Due to Competing Risks and Different Data Types, with Application to Stroke Prevention in Atrial Fibrillation

    Nov 1, 2016, 00:00

  • How are Budget Impact Considerations Captured within Economic Evaluations? A Systematic Review of the Literature Focused on Rotavirus Vaccine

    Nov 1, 2016, 00:00

  • Global Prevalence Estimates of Transthyretin Familial Amyloid Polyneuropathy (ATTR-FAP)- A Systematic Review and Projections

    Nov 1, 2016, 00:00

  • Improvement of Long Term Risks of Cardiovascular Events Associated with Community Based Disease Management in Chinese Patients of the Xin Jiang Autonomous Region of China

    Nov 1, 2016, 00:00

  • The Economic Burden of Pulmonary Embolism in Europe

    Nov 1, 2016, 00:00

  • Rate and Healthcare Utilization (Los and Costs) of Adhesion Related Complications after Colon Resection Procedures

    Nov 1, 2016, 00:00

  • Supply-Side and Demand-Side Policies for Biosimilars- An Overview in 10 European Member States

    Nov 1, 2016, 00:00

  • Economic Burden of Community-Acquired Pneumonia Among Elderly

    Nov 1, 2016, 00:00

  • Surgical Site Complications- to Prevent or Not to Prevent? A Budget Impact Analysis in the Hospital Setting

    Nov 1, 2016, 00:00

  • Certolizumab Pegol is Associated with Long-Term Improvements in Patient-Reported Outcomes in Psoriatic Arthritis- 4-Year Outcomes from the Rapid-Psa Study

    Nov 1, 2016, 00:00

  • Factors Associated with 90-Day or 180-Day Long-Term Use of Anxiety-Hypnotic Prescriptions and Economic and Safety Outcomes- A Retrospective Cohort Study

    Nov 1, 2016, 00:00

  • Landscape of Advanced NSCLC- The Impact of Upcoming Therapies

    Nov 1, 2016, 00:00

  • What EU Mean to the MHRA! Potential Impact of ‘Brexit’ on Pharmaceutical Regulation in the UK

    Nov 1, 2016, 00:00

  • Pain Management of Lung Cancer Patient in Hungary

    Nov 1, 2016, 00:00

  • The Multidisciplinary Risk Assessment and Management Program – Diabetes Mellitus (Ramp-Dm) was Cost-Effective for Managing Patients with Diabetes Mellitus

    Nov 1, 2016, 00:00

  • A Comprehensive Economic Model for Dementia- Diagnosis, Disease Progression and Service Delivery

    Nov 1, 2016, 00:00

  • Estimating the Economic Burden of Treatment Resistant Depression in Taiwan using the NHIRD

    Nov 1, 2016, 00:00

  • Retrospective Database Analysis of Hospital Length of Stay, Discharge Location, And Readmissions Among Patients Undergoing Total Knee Arthroplasty (TKA) In The United States

    Nov 1, 2016, 00:00

  • • Analysis of The Factors Affecting Parents’ Medication Adherence In Asthmatic Children Using Expectation Confirmation Theory

    Nov 1, 2016, 00:00

  • Empirical Calibration of Hepatitis C Virus (HCV) Natural History Model to the Chinese HCV-Infected Population

    Nov 1, 2016, 00:00

  • Prioritizing Medication Problems in Care of People with Cancer and Solutions For These- A Prioritize Study

    Nov 1, 2016, 00:00

  • Cost Utility of Transfer Factor In The Treatment of Recurrent Infection`S Episodes In Adult And Pediatric Subjects From A Final Results From Multicentre Observational Study

    Nov 1, 2016, 00:00

  • The Importance of Conitec Recommendation about Analogues Insulins of The Treatment of Diabetes Type 1

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Combination Therapy with Dutasteride/Tamsulosin- An Analysis Based on Conduct Trial

    Nov 1, 2016, 00:00

  • Health Insurance Cost Of Multiple Sclerosis In Hungary- A Cost Of Illness Study

    Nov 1, 2016, 00:00

  • Use of Novel Health-Related Quality of Life Measures to Assess The Effect of Metamorphopsia Symptoms In Patients with Vitreomacular Traction, With or Without Macular Hole- The Memo Study

    Nov 1, 2016, 00:00

  • Diabetic Macular Edema, Budget Impact Analysis from the Perspective of the Algerian Public Health System

    Nov 1, 2016, 00:00

  • Are Component Endpoints Equal? A Study into the Practice of Composite End Points in Clinical Trials

    Nov 1, 2016, 00:00

  • Current Status of Endoscopic Submucosal Dissection for Gastric Cancer Within Absolute Indication in Korea- Based on National Claims Database

    Nov 1, 2016, 00:00

  • Psychometric Validation Of Four Patient-Reported Outcome Instruments In A Diverse Sample Of Adults With Chronic Hepatitis C Virus Infection Treated With Simeprevir And Sofosbuvir

    Nov 1, 2016, 00:00

  • A Health Technology Assessment of Home-Based Haemodialysis in Esrd Patients

    Nov 1, 2016, 00:00

  • Adaptive Reimbursement Model- How to Correlate The Price to The Level of Evidences During The Entire Drug Life Cycle

    Nov 1, 2016, 00:00

  • Current and Preferred Status on HTA Implementation- A Ukrainian Perspective

    Nov 1, 2016, 00:00

  • When Should Translations of Clinical Outcome Assessments (COAS) be Considered Obsolete? Recommendations from MAPI’S Translations Life Expectancy Working Group

    Nov 1, 2016, 00:00

  • Cone Beam Computed Tomography use in Overdenture Abutments Examination- Risk Benefit Analysis

    Nov 1, 2016, 00:00

  • Man Versus Machine - Is Accurate Automation of Data Abstraction Achievable?

    Nov 1, 2016, 00:00

  • Medical Care Costs of Diabetes Using an Instrumental Variable Approach

    Nov 1, 2016, 00:00

  • Dimensionality Of Value- Are The Us And Europe Moving Towards Similar Or Different Definitions Of Pharmaceutical Value?

    Nov 1, 2016, 00:00

  • Ofatumumab As A Combination Therapy Versus Other Treatment Regimens in Patients with Untreated, Relapsed or Refractory Chronic Lymphocytic Leukaemia- A Systematic Review of Randomised Controlled Trials

    Nov 1, 2016, 00:00

  • Recent Trends in Percutaneous Coronary Intervention Volume in the United States

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Xpert MTB/RIF Assay for Diagnosing Tuberculosis in Malaysia Using Dynamic Transmission Model

    Nov 1, 2016, 00:00

  • Workload Analysis Of Parenteral Nutrition Services At Ministry Of Health Hospital In Saudi Arabia

    Nov 1, 2016, 00:00

  • Utility Values in Economic Models for Treatments of Schizophrenia

    Nov 1, 2016, 00:00

  • Characteristics and Quality of Life in Peripheral Arterial Disease(Pad) Patients In Korea- Results From Pad Outcomes Research

    Nov 1, 2016, 00:00

  • Real-World Treatment Pattern in Community Patients with Type-2 Diabetes- Evidence from Shanghai, China

    Nov 1, 2016, 00:00

  • Comparative Analysis of Indirect Costs Associated with Chronic Spontaneous/Idiopathic Urticaria-Results From The Assure-Csu Study In 7 Countries

    Nov 1, 2016, 00:00

  • Application Limitations of Cost Minimization Analysis in China

    Nov 1, 2016, 00:00

  • Description of the Impact of Hypertension on Hospitalisations for Cardiovascular Diseases in Japan Using a Japanese Claims Database

    Nov 1, 2016, 00:00

  • Reliability and Validity Study of the Finnish Adaptation of Scoliosis Research Society Questionnaire Version SRS-30

    Nov 1, 2016, 00:00

  • The Safety And Effectiveness of Autologous Platelet Rich Plasma (Prp) Therapy For Lateral Epicondylitis- Systematic Reviews

    Nov 1, 2016, 00:00

  • Performance of Search Filters to Identify Health State Utility Studies

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Dasatinib in Imatinib-Resistant Or-Intolerant Patients with Chronic Phase Chronic Myeloid Leukemia (Cml-Cp) in the Chinese Setting

    Nov 1, 2016, 00:00

  • Cost of Outreach-Programme Toward Sex Workers in the NGO and Primary Health Center in Indonesia

    Nov 1, 2016, 00:00

  • Continental Comparison of Innovative Drugs Prices, The Case of Oncology Used for Treatment of Solid Tumors in Germany and The United States

    Nov 1, 2016, 00:00

  • Effectiveness of Photodynamic Therapy in Patients with Localized Esophageal Cancer

    Nov 1, 2016, 00:00

  • A Retrospective Study of Healthcare Costs in Patients with end Stage Lung Cancer During The Last Six Months of their Life

    Nov 1, 2016, 00:00

  • Quetiapine Off-Label Use

    Nov 1, 2016, 00:00

  • Trends In Utilization of Smoking Cessation Agents Before and After The Passage of Black Box Warning in The United States

    Nov 1, 2016, 00:00

  • Adjusted Comparison of Daratumumab Monotherapy Versus Real-World Historical Control Data From The Czech Republic in Heavily Pre-Treated and Highly Refractory Multiple Myeloma Patients

    Nov 1, 2016, 00:00

  • Recommendations In Clinical Guidelines, ‘No Benefit’ Ratings, And Opt-Out Decisions In Germany Since The Introduction Of The Amnog Law In 2011- How Do The Pieces Fit Together?

    Nov 1, 2016, 00:00

  • Literature Review On Morbidity and Mortality Endpoints in Melanoma Patients Under Treatment With GM-CSF or Dacarbazine

    Nov 1, 2016, 00:00

  • Efficacy, Costs And Quality Of Life In The Real World Setting For Patients With Multiple Sclerosis Treated With Fingolimod- Intermediate Results From The Virgile Study

    Nov 1, 2016, 00:00

  • Assessment Of Price Of Essential Medicines In India

    Nov 1, 2016, 00:00

  • Methods For The Design And Conduct Of Medical Record Reviews In Oncology

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Take Home-Naloxone for the Prevention Of Fatalities from Heroin Overdose in the UK

    Nov 1, 2016, 00:00

  • Towards more Transparent HTA Process in Poland – New Polish HTA Methodological Guidelines

    Nov 1, 2016, 00:00

  • prevalence of Anticholinergic Drug Use in Older Adults With Dementia

    Nov 1, 2016, 00:00

  • Real Time Patient Reported Outcomes Assessment in Routine Rheumatology Clinic - Feasibility Study of Myra Touch

    Nov 1, 2016, 00:00

  • Segmentation of Seven Asia-Pacific Health Technology Assessment (HTA) Agencies into Different Evolutionary HTA Archetypes

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Bisphosphonates for Primary and Secondary Prevention of Hip-Related Fracture with Glucocorticoid-Induced Osteoporosis in Malaysia

    Nov 1, 2016, 00:00

  • Predicting Response To Anti-Vascular Endothelial Growth Factor Treatment Using Electronic Medical Record Data In Eyes With Neovascular Age-Related Macular Degeneration

    Nov 1, 2016, 00:00

  • Comparative Analysis of Clinical Trial Attributes in Pivotal Studies for Orphan vs. Non-Orphan Oncology Products FDA-Approved between 2011 and 2015

    Nov 1, 2016, 00:00

  • Markov Model Projection Of Regional Physician Supply In Turkey Shows That Physician Density Will Not Change Substantially In The Next 15 Years

    Nov 1, 2016, 00:00

  • The Impact of External Price Referencing Within and Across a Country's Borders

    Nov 1, 2016, 00:00

  • Identification of Statin Intoleran Results From a Survey of Clinicians in Japan

    Nov 1, 2016, 00:00

  • The Direct Cost-Components in Pulmonary Arterial Hypertension- An Expert Panel Approach for Estimation of Costs

    Nov 1, 2016, 00:00

  • Market Share of Addictology According To The System of Diagnosis Related Groups (DRGS) In Hungary

    Nov 1, 2016, 00:00

  • Utility Measures and Quality-Adjusted Life Years In Patients with Symptomatic Multivessel Coronary Artery Disease Assigned To Surgery, Angioplasty or Medical Treatment – Mass II Trial

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Ranibizumab Compared to Dexamethasone in Patients with Retinal Vein Occlusion (RVO) from A Portuguese Health Care Perspective

    Nov 1, 2016, 00:00

  • Racial Differences in Cardiovascular Disease in The United States- Healthcare Resource Utilization and Costs

    Nov 1, 2016, 00:00

  • Effectiveness and Safety of Thrombolytic Agents Streptokinase, Alteplase and Tenecteplase in the Treatment of Acute Myocardial Infarction

    Nov 1, 2016, 00:00

  • Economic Burden of Myelodysplastic Syndromes In Croatia

    Nov 1, 2016, 00:00

  • Development of a Global Model for the Economic Evaluation of Pharmacogenomics Tests for Early-Stage Breast Cancer Treatment

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Exenatide Once Weekly Versus Insulin Glargine and Liraglutide for the Treatment of Type 2 Diabetes in Greece

    Nov 1, 2016, 00:00

  • Mapping of Existing Data Sources for the Conduct of Real-World Studies in Progressive Supranulcear Palsy (PSP) in North America, Europe and Japan

    Nov 1, 2016, 00:00

  • Health-Related Quality of Life of Patients in Primary Care and Multimorbity

    Nov 1, 2016, 00:00

  • A Dynamic Simulation to Investigate Health Economic Impact of a Pulmonary Artery Pressure Sensor for Heart Failure Telemonitoring

    Nov 1, 2016, 00:00

  • Discordance Between Knowledge of Cardiovascular Risk Factors and Ideal Cardiovascular Health in Hong Kong Adults

    Nov 1, 2016, 00:00

  • Economic Evaluation Of Yellow Fever Routine Vaccination In Colombia

    Nov 1, 2016, 00:00

  • Comparison of Orphan Drug Market Access in A Sample of EU Countries, Ausralia, Canada and US

    Nov 1, 2016, 00:00

  • The Impact Of Regional Legislative Measures On The Prescription Of Off-Patent Medicines

    Nov 1, 2016, 00:00

  • Assessment of Utility for Heart Failure using Visual Analogue Scale(VAS), Time-Trade off(TTO) and Euroqol-5 Dimension(EQ-5D) in the Korean General Population

    Nov 1, 2016, 00:00

  • Non-Valvular Atrial Fibrillation- Can We Improve Health Outcomes?

    Nov 1, 2016, 00:00

  • Using Analytic Hierarchy Process to Weight Patient-Relevant Outcomes in the Treatment of Psoriasis for Calculating the Patient Benefit Index

    Nov 1, 2016, 00:00

  • The Behaviour Of Pharmacists In Public Pharmacies In Relation To The Cold Regime Drugs

    Nov 1, 2016, 00:00

  • Evaliation of Utility Index of Quality of Life In Hepatitis Patients in Japan

    Nov 1, 2016, 00:00

  • Evaluation of Breast Cancer HER2 Status Accuracy Using A Predictive Model Based on Her-France Real World National Database

    Nov 1, 2016, 00:00

  • Epidemiology, Treatment Pathways and Costs of Cancers Potentially Related to HPV Infection in France

    Nov 1, 2016, 00:00

  • Economic Evaluation of Cancer Medicines Usage at Uganda Cancer Institute

    Nov 1, 2016, 00:00

  • Personalized Adaptive Rewards Versus Incentives to Motivate Sustainable Healthy Behavioral Change- A Neo-Maslowian Conceptual Model

    Nov 1, 2016, 00:00

  • Reliability and Validity of the Short-Form 36 (SF-36) Health Survey in Patients with Spondyloarthritis

    Nov 1, 2016, 00:00

  • A Study Comparing the Evolution of Different Proceeses for Patient Input in Different European HTA Systems Since 2011

    Nov 1, 2016, 00:00

  • Health Related Quality of Life for Disease Population in China- A Systematic Review

    Nov 1, 2016, 00:00

  • Lost in Translation- Randomised Controlled Trial and Systematic Review Evidence of Intracoronary Versus Intravenous Abciximab in St-Elevation Myocardial Infarction

    Nov 1, 2016, 00:00

  • Comparative Effectiveness of Carbapenems Versus Alternative Antibiotics for the Treatment of Bacteraemia Due to Enterobacteriaceae Producing Extended-Spectrum β-Lactamase in Empirical Therapy- Multicenter Cohort Study

    Nov 1, 2016, 00:00

  • Nintedanib Cost-Effectiveness In Idiopathic Pulmonary Fibrosis In The UK

    Nov 1, 2016, 00:00

  • Estimating the Impact of Direct-to-Consumer Advertising of Pharmacy Only Medicine Using Discrete Choice Experiments

    Nov 1, 2016, 00:00

  • Quality of Life Measured with Eq-5d in Patients with Major Depressive Disorder in Japan

    Nov 1, 2016, 00:00

  • Cost and Burden of Female Breast Cancer in Portugal

    Nov 1, 2016, 00:00

  • The Effectiveness of Lean Body Mass Analysis Using Dual Energy X-Ray Absorptiometry (DEXA) for Diagnosis of Sarcopenia

    Nov 1, 2016, 00:00

  • Length of Stay, Costs and Mortality Attributable to Clostridium Difficile Infections in 13 Belgian Hospitals

    Nov 1, 2016, 00:00

  • Factors Associated with The Mental and Physical Health-Related Quality of Life (HRQOL) of Asthma Patients- A Cross-Sectional Analysis Based On 673 Patients

    Nov 1, 2016, 00:00

  • Provisions and Special Considerations for Rare Diseases / Orphan Drugs by Health Technology Assessment (HTA) Bodies- Systematic Evaluation in 25 Countries

    Nov 1, 2016, 00:00

  • Analysis Of Influenza Vaccination Effectiveness In General Practitioner

    Nov 1, 2016, 00:00

  • Role of Tiered Pricing Policy in Improving Access to Medicines in India

    Nov 1, 2016, 00:00

  • Economic Burden of Hospitalization for Hepatic Encephalopathy in Fran An Analysis of Cost Discriminating Factors By Patient Profile

    Nov 1, 2016, 00:00

  • Amnog Early Benefit Assessment (EBA) in Germany - A Specific Challenge for Antidiabetics

    Nov 1, 2016, 00:00

  • Medication Errors Avoided by Medication Reconciliation Process at Female Surgery Ward in Ramathibodi Hospital, Thailand

    Nov 1, 2016, 00:00

  • Free Essential Medicines Through Public Health Facilities in Nepal- A Qualitative Study

    Nov 1, 2016, 00:00

  • The Epidemiology and Cardiovascular Disease Risk Assessment of Patients Currently on Lipid Lowering Treatment with Statin- Nationwide Cross-Sectional Study in Korea

    Nov 1, 2016, 00:00

  • Impacts of Adverse Events on Health-Related Quality of Life in Patients Receiving First-Line Chemotherapy for Metastatic Breast Cancer- Results From Randomized Phase III Select BC Study

    Nov 1, 2016, 00:00

  • Impact of Etanercept Biosimilar Launches on Healthcare Spending- A UK Budget Impact Model For The Treatment of Rheumatoid Arthritis And Chronic Plaque Psoriasis

    Nov 1, 2016, 00:00

  • Assessing Patient Preference for Insulin Intensification in France

    Nov 1, 2016, 00:00

  • Pharmacoeconomics Analysis of ACEI and ARB Against Essential Hypertension- A Case Study of Shanghai

    Nov 1, 2016, 00:00

  • Impact of a Community Pharmacy-Based Information Program on Type 2 Diabetic Patients’ Adherence to Their Oral Treatment- Iphodia, A Cluster Randomized Study Vs Usual Practice

    Nov 1, 2016, 00:00

  • What is Real-World Data?- A Review of Definitions Based on Literature Stakeholder Interviews

    Nov 1, 2016, 00:00

  • Review Of National Policies For Rare Diseases Across Eu Countries

    Nov 1, 2016, 00:00

  • Does Real World Evidence Support Conclusions From Experimental Evidence In Decision-Making Processes In Poland?

    Nov 1, 2016, 00:00

  • Economic Resources Optimisation In The Hcv Setting- The Role Of The Daas

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis Evaluating Vortioxetine Versus Venlafaxine XR and Agomelatine in the Treatment of Major Depressive Disorder in Taiwan

    Nov 1, 2016, 00:00

  • Feasibility, Reliability and Validity of The Decision Tool Unipolar Depression (DTUD) In Identifying Patients with Major Depressive Disorder in Need of Highly Specialized Care

    Nov 1, 2016, 00:00

  • Economic Impact of Olaparib in Patients with Platinum Sensitive Relapsed Brca Mutated Epithelial Ovarian Cancer in Spain

    Nov 1, 2016, 00:00

  • Complete Remission and Survival Ratio Comparison Between Transplant and Non-Transplant AML Patients Receiving Standard Regimen in a Malaysian Hospital

    Nov 1, 2016, 00:00

  • Burden of Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome (ACOS)

    Nov 1, 2016, 00:00

  • A Review of Pharmeceutical Policies in Response to Economic Crisis and Sanctions

    Nov 1, 2016, 00:00

  • Costs And Outcomes Of Hospital Infections In Italy

    Nov 1, 2016, 00:00

  • Study of Contrast Induced Nephropathy in Patients Undergoing Cardiac Catheterization- Upper Egypt Experience

    Nov 1, 2016, 00:00

  • Effectiveness of Photodynamic Therapy in Patients with Non-Small Cell Lung Cancer- A Population Based Study

    Nov 1, 2016, 00:00

  • A Retrospective, Cross Sectional Study on The Prevalence of Hyperuricemia Using A Healthcare Database In Japan

    Nov 1, 2016, 00:00

  • Acute Respiratory Distress Syndrome Profile at a Tertiary Care Teaching Hospital in South India

    Nov 1, 2016, 00:00

  • Long-Term Healthcare Costs of Patients with Symptomatic Peripheral Artery Disease with and without a History of Atherosclerotic Disease- Results from a Swedish Nationwide Study

    Nov 1, 2016, 00:00

  • Current Perioperative Use of Orodental Antiseptics In Implant Surgery In Bulgaria

    Nov 1, 2016, 00:00

  • Impact of Community Care Subsidies on Care Use Of Elderly People

    Nov 1, 2016, 00:00

  • Metastatic Colorectal Cancer- The Burden of Illness in The Uk and Ireland

    Nov 1, 2016, 00:00

  • Strategic Considerations to Engage in Early Advice with European Health Technology Assessment Bodies

    Nov 1, 2016, 00:00

  • Rationing Resources in Health By Involving the Public in Priority Setting

    Nov 1, 2016, 00:00

  • The Economic Impact of Schizophrenia from an English NHS Perspective Based on Estimates from Electronic and Self-Reported Methods of Data Collection

    Nov 1, 2016, 00:00

  • Prescription Patterns and Drugs Costs in Patients with Dementia - A Retrsopective Database Analysis

    Nov 1, 2016, 00:00

  • Medical Costs Attributable To Obesity In Working Osteo-Arthritis Patients In The US

    Nov 1, 2016, 00:00

  • Economic Evaluation of Pertuzumab Neoadjuvant Treatment for Patients with Locally Advanced, Inflammatory, or Early Stage HER2-Positive Breast Cancer in Greece

    Nov 1, 2016, 00:00

  • Effects of The Mental Health Parity and Addictions Equality Act on Depression Treatment Choice in Primary Care Facilities in The United States

    Nov 1, 2016, 00:00

  • Real-World Outcomes of Novel Treatments in Patients with Advanced Melanoma in The Netherlands

    Nov 1, 2016, 00:00

  • Japan Health Care Act Reform- Toward Decentralization And Integrated Health Care System

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis for Apixaban in The Acute Treatment and Prevention of Venous Thromboembolism in The Netherlands

    Nov 1, 2016, 00:00

  • Patient Preferences Versus Physician Perceptions Of Treatment Decisions In Advance Stage Prostate Cancer

    Nov 1, 2016, 00:00

  • Physical Activity and Health-Related Quality of Life Among Adults with Type 2 Diabetes- Results from Wearable Fitness Trackers

    Nov 1, 2016, 00:00

  • Adoption of Oncology Biosimilars in Europe

    Nov 1, 2016, 00:00

  • Estimation Of Value Of Life With A Model Approach Depending On Net Present Value For Austria, Canada, Japan And Usa

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis of Sacubitril/Valsartan for The Treatment of Chronic Heart Failure in Greece

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis of Atazanavir/Ritonavir 200/100 Mg Versus Atazanavir/Ritonavir 300/100 Mg in Thai Adults with Virologic Suppression

    Nov 1, 2016, 00:00

  • Receipt and Delivery of Medication Risk and Safety Information- Perceptions of Consumers and Healthcare Professionals (HCPS) in the US

    Nov 1, 2016, 00:00

  • Antimicrobial Susceptibility Pattern in Chronic Suppurative Otitis Media Patient in a Tertiary Care Hospital

    Nov 1, 2016, 00:00

  • The 21-Gene Assay In The Decision Impact Assessment of ER+, HER2- Breast Cancer- A French Real Life Prospective Study

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Evaluation of Vortioxetine in Major Depressive Episode in the UK Setting

    Nov 1, 2016, 00:00

  • Adherence To Gold Criteria Strategy In Treatment of Chronic Obstructive Pulmonary Disease (COPD) Patients- Cost Implications In Turkey

    Nov 1, 2016, 00:00

  • Identification of Statin Intoleran Results From A Survey of South Korean Clinicians

    Nov 1, 2016, 00:00

  • Use of the Pert and Uniform Distributions with the Central Limit Theorem (CLT) to Decrease Variance in Complication Cost Estimation in Probabilistic Models

    Nov 1, 2016, 00:00

  • Quality of Life in Patients with Diabetes Mellitus II in Czech Republic

    Nov 1, 2016, 00:00

  • Early HTA in Pharmacogenomics- A Case Example in Cardiovascular Drugs

    Nov 1, 2016, 00:00

  • Tamoxifen for the Primary Prevention of Breast Cancer- New Life for an Old Drug

    Nov 1, 2016, 00:00

  • An Analysis of the Efficacy and Safety of Edoxaban in Comparison with Rivaroxaban in the Treatment of Deep Vein Thrombosis and Pulmonary Embolism

    Nov 1, 2016, 00:00

  • Development of Reimbursement of New Examination and Treatment Methods (NUB) in the German DRG-System – Analysis of NUB Applications and NUB Status Since Implementation

    Nov 1, 2016, 00:00

  • Types of Risk-Sharing Schemes Proposed in Reimbursement Application Received by Aotmit in 2015

    Nov 1, 2016, 00:00

  • The Evaluation of Innovative Drugs Applying Business Valuation Concepts

    Nov 1, 2016, 00:00

  • Real-World Treatment Patterns and Costs of Care Among Brentuximab Vendotin-Treated Patients with Hodgkin Lymphoma in The United States

    Nov 1, 2016, 00:00

  • Cost Analysis of the Molecular Screening and Genetic Diagnosis of Lynch Syndrome in Catalonia (Spain)

    Nov 1, 2016, 00:00

  • Economic Burden of Medical Transports In France over The Year 2014

    Nov 1, 2016, 00:00

  • Effectiveness of Pharmacists-Led Provider-Focused Interventions to Improve Hpv Vaccination Rates in Adults in Malaysia

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Of Levofloxacin Inhalation Solution Vs. Aztreonam Inhalation Solution In Cystic Fibrosis Patients In Belgium

    Nov 1, 2016, 00:00

  • On a Design Issue of EQ-5D-3l Valuation Studies- Should Likelihood of the Health States Be Considered?

    Nov 1, 2016, 00:00

  • Real-World Outcomes of Ipilimumab in Patients with Advanced Melanoma in The Netherlands

    Nov 1, 2016, 00:00

  • Micro-Costing Analysis of Procedures on Varicose Veins Performed in Outpatient Setting

    Nov 1, 2016, 00:00

  • The Public Health Perspective Of An Investigational Herpes Zoster Vaccine In The United Kingdom (Uk)

    Nov 1, 2016, 00:00

  • Relationship Between Orphan Disease Prevalence, Differential Hta Value Assessment, And Orphan Drug Pricing In Seven European Countries

    Nov 1, 2016, 00:00

  • Costs and Clinical Outcomes in The Management of Metastatic Castration-Resistant Prostate Cancer in Greece

    Nov 1, 2016, 00:00

  • Monitoring Evidence-Based Technology Incorporation- The Case of Biological Rheumatoid Arthritis Drugs In Brazil From 2010 to 2014

    Nov 1, 2016, 00:00

  • Comparison of Methods for Indirect Treatment Comparison Combining Individual and Aggregate Patient Data- A Simulation

    Nov 1, 2016, 00:00

  • The Economic Cost Of Blindness in Europe

    Nov 1, 2016, 00:00

  • Health Related Quality of Life Among Patients with Heart Failure in South Korea

    Nov 1, 2016, 00:00

  • Analysis of the Indicator "Threshold Willingness To Pay" in Leukemia Patients by Gender According to the Survey in Ukraine

    Nov 1, 2016, 00:00

  • Assessment Of Clinical And Economic Outcomes Of Pharmacist Intervention In Total Parenteral Nutrition Program In Saudi Arabia

    Nov 1, 2016, 00:00

  • CT And MRI Units In Cyprus- A Market Analysis

    Nov 1, 2016, 00:00

  • A Cost of Illness Analysis of Pulmonary Arterial Hypertension in Greece

    Nov 1, 2016, 00:00

  • A Cost-Minimization Analysis of Dermatophyte Test Kit with Onychomycosis Under Health Care System in Japan

    Nov 1, 2016, 00:00

  • Albuminuria and Serum Creatinine in Predicting Renal Function Decline in Patients with Diabetic Nephropathy- A Systematic Literature Review

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Secukinumab Compared with Ustekinumab And Etanercept for the Treatment Of Moderate-to-Severe Plaque Psoriasis in Greece

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis of Lorcaserin In The Treatment of Obesity

    Nov 1, 2016, 00:00

  • Prevalence and Environmental Risk Factors of Self-Reported Acne in Mexico

    Nov 1, 2016, 00:00

  • Epidemiology of Chronic Kidney Disease and Predictors of Hyperkalemia- Analysis of Nhanes 2007–2014

    Nov 1, 2016, 00:00

  • Treatment Gap of Ulcerative Colitis In Children And Adolescents In Poland - Cost-Utility Analysis of Biosimilar Infliximab

    Nov 1, 2016, 00:00

  • Patient Preferences In The Treatment of Neovascular Age-Related Macular Degeneration- A Discrete Choice Experiment

    Nov 1, 2016, 00:00

  • Metformin Treatment and Homocysteine- A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Nov 1, 2016, 00:00

  • A Methodological Issue in Effectiveness Studies of Malaria Vaccines and Chemoprevention

    Nov 1, 2016, 00:00

  • Comparison Study Based on Simulation of Patient Pathways Using Multi-State Models in Oncology

    Nov 1, 2016, 00:00

  • The Impact on Long-Term Targeted Therapy with Omalizumab on The Quality of Life According To Registry of Children with Uncontrolled Severe Persistent Asthma (Russian Experience)

    Nov 1, 2016, 00:00

  • The Public Health Impact Of A New Herpes Zoster Vaccine To The German Population

    Nov 1, 2016, 00:00

  • Use of Clinical Intelligence in Monitoring Rational Drug Use Indicators in Thailand

    Nov 1, 2016, 00:00

  • Current Practice of Drug Treatment In Children with ILD- First Insights From The Child-Eu Registry

    Nov 1, 2016, 00:00

  • A Comparative Analysis on Health Security System Between China and Developed Countries

    Nov 1, 2016, 00:00

  • The Costs of Rheumatoid Arthritis In Finland

    Nov 1, 2016, 00:00

  • Assessing The Outcomes of Prosthetic Treatment in Lower Overdenture Wearers

    Nov 1, 2016, 00:00

  • A Cost-Effectiveness Analysis of Biosimilar Infliximab (Inflectra®) For The Treatment of Psoriatic Arthritis In Nine European Countries

    Nov 1, 2016, 00:00

  • The Cost of Remaining NTM Positive- Health Care Utilization and Costs In A Sample of Patients with Refractory Pulmonary Disease Due To Mycobacterium Avium Complex In Canada, Germany, United Kingdom And France

    Nov 1, 2016, 00:00

  • Cost Effectiveness of Contrast-Enhanced Liver MRI in the Characterisation of Suspected Liver Lesions in Patients with Colorectal Cancer

    Nov 1, 2016, 00:00

  • Health-Related Quality of Life for People Suffering from Severe Chronic Low Back Pain with a Neuropathic Component- Results from a Post-Hoc Analysis of Randomly Selected Routine Data, Evaluated By Response to Treatment

    Nov 1, 2016, 00:00

  • Accuracy Of Natural Language Processing-Based Classifiers For Automated Identification Of Abstracts Of Studies On Humanistic And Economic Burden Of Disease

    Nov 1, 2016, 00:00

  • Economic Evaluation of ASA 100mg, Simvastatin 40mg and Ramipril 5-10mg (POLYPILL) for Secondary Prevention of Cardiovascular Events in Mexico

    Nov 1, 2016, 00:00

  • A Time and Motion Cost Analysis of Oral Vinorelbine Versus Iv Chemotherapies For Patients with Advanced Non-Small Cell Lung Cancer (Nsclc) and Metastatic Breast Cancer (Mbc)From Chinese Societal Perspective

    Nov 1, 2016, 00:00

  • A Retrospective Study on The Management of Primary Immune Thrombocytopenia In Adult Patient In Hong Kong

    Nov 1, 2016, 00:00

  • Understanding Racial And Ethnic Differences In End of Life Care For Hospitalized Patients

    Nov 1, 2016, 00:00

  • The Burden of Inflammatory Bowel Disease(IBD) in Japan

    Nov 1, 2016, 00:00

  • Reducing disparities in u.s. Vaccination through senior centers- A Comparison of three Educational Models for Older African Americans

    Nov 1, 2016, 00:00

  • Health Care Resource Utilization and Costs Associated with the Management of Non-Infectious Intermediate, Posterior and Panuveitis in Canada

    Nov 1, 2016, 00:00

  • Risk of Cardiovascuar Disease in Type 2 Diabetic Women on Sulfonylureas-A Retrospective Case-Control Study

    Nov 1, 2016, 00:00

  • The Effect of Diabetes on the Quality-of-Life in Community-Dwelling Elderly in The Netherlands

    Nov 1, 2016, 00:00

  • Two Models of Public Educations, Storytelling Animated Movies- Cons And Pros

    Nov 1, 2016, 00:00

  • Assessment of the Costs of Overall Children Vaccination with Antirotavirus Vaccine in Ukraine

    Nov 1, 2016, 00:00

  • Assesing The Average Price Level Of Generics In Greece And Other Comparable European Countries Relative To Their Volume Market Share

    Nov 1, 2016, 00:00

  • Predicting Patient-Reported Outcomes from Disease-Specific Questionnaires- A Comparison of Seven Methodologies

    Nov 1, 2016, 00:00

  • Modeling The Impact Of Reform To The Cancer Drugs Fund

    Nov 1, 2016, 00:00

  • Adoption of Endoscopic Lung Volume Reduction for Emphysema in Germany- Utilization Patterns and Case Volumes in the Period 2010-2014

    Nov 1, 2016, 00:00

  • Inpatient Costs of Agitation and Containment in an Urban Area

    Nov 1, 2016, 00:00

  • Italian Timings In New Drugs Approval- An Up-To-Date Analysis

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Evaluation Of Phid-Cv Versus Pcv-13 In Poland

    Nov 1, 2016, 00:00

  • Estimating an Icer with NOAC Versus Warfarin in Atrial Fibrillation

    Nov 1, 2016, 00:00

  • Orphan Drug Shortage in The United States- A Long Lasting Public Health Issue Calling for Effective Policies

    Nov 1, 2016, 00:00

  • The Benefits of A Holistic View- Considering Multiple Health Outcomes for Hiv and Sti Testing

    Nov 1, 2016, 00:00

  • Healthcre Reform Plan and Price Elasticity in Vaginal Delivery- A Case Study in Iran

    Nov 1, 2016, 00:00

  • Treatment Efficacy in Sequence Modelling – A Review of Published Approaches

    Nov 1, 2016, 00:00

  • Effect of Drug Cost-Sharing Change on Non-Adherence to Essential Medications for Acute Coronary Syndrome- A Population Based Natural Experiment

    Nov 1, 2016, 00:00

  • Economic Evaluation Guideline for Pharmaceuticals and Medical Devices in Japan

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Using Factor VII + Von Willebrand Factor In Treatment of Patients with Von Willebrand Disease

    Nov 1, 2016, 00:00

  • Evaluation of Antimicrobial Stewardship Programs in Hainan, China

    Nov 1, 2016, 00:00

  • German Travelers’ Preferencences For Vaccines Against Travel-Related Illnesses

    Nov 1, 2016, 00:00

  • Dose Escalation of Biologics in Crohn’s Disease- Summary of Observational Studies in the UK

    Nov 1, 2016, 00:00

  • Analysis of Rational Medication for Cardiovascular Diseases in Fujian, China

    Nov 1, 2016, 00:00

  • Study of Prescribing Pattern of Anti-Diabetic Drugs in Newly Diagnosed Type 2 Diabetes Mellitus

    Nov 1, 2016, 00:00

  • ASSESSMENT OF PET/CT USE IN RADIOTHERAPY PLANNING VERSUS CT SCANS USE ONLY

    Nov 1, 2016, 00:00

  • Long-Term Improvements in Workplace and Household Productivity and Social Participation Over 4 Years of Certolizumab Pegol Treatment in Patients with Psoriatic Arthritis, with and without Prior Anti-Tnf Exposure

    Nov 1, 2016, 00:00

  • Economic Assessment of Routine Oncotype DX Testing of Estrogen Receptor Positive (ER+) Early Breast Cancer (EBC) Patients with Grade 2 Tumours in Czech Republic

    Nov 1, 2016, 00:00

  • Advanced Therapy Medicinal Products for Alzheimer's Disease Will Shrink the National Health Service Budget

    Nov 1, 2016, 00:00

  • Effect Of A Pay-For-Performance Program For Diabetes On Health Status (Eq-5d) In Taiwan

    Nov 1, 2016, 00:00

  • Type 2 Diabetes- How Much Does it Cost During the First 8 Years after the First Antidiabetic Treatment? A Dynamic Approach from the French National Health Insurance

    Nov 1, 2016, 00:00

  • Understanding Health Technology Assessment (HTA) Bodies in Major European Markets- Systematic Evaluation in 10 EU Countries

    Nov 1, 2016, 00:00

  • Persistence with Biologic Agents for the Treatment of Rheumatoid Arthritis in Japan

    Nov 1, 2016, 00:00

  • Prompt Value Assessment Of Breakthrough Interventions With Limited Outcome Data

    Nov 1, 2016, 00:00

  • Upcoming Regulations on Insurance Reimbursement Standard in China- Chanllanges and Opportunites for Mncs

    Nov 1, 2016, 00:00

  • Cross-Cultural Adaptation of the Zarit Caregiver Interview for Alzheimer's Disease (ZCI-AD) and the Caregiver Global Impression Scales in 13 Languages

    Nov 1, 2016, 00:00

  • A Systematic Review and Meta-Analysis of the Prevalence and Complications of Paraphenylene Diamine (PPD) Containing Hair Dye Poisoning in Developing Countries

    Nov 1, 2016, 00:00

  • Towards Better Coordination and More Efficient Patient Pathways in Copd

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Diagnostic Tests for People At Risk of Non-Alcoholic Fatty Liver Disease (NAFLD) in The UK

    Nov 1, 2016, 00:00

  • Examining The Association Between Corticosteroid Exposure and New Onset Type 2 Diabetes Among Commercially Insured Copd Patients In The US

    Nov 1, 2016, 00:00

  • Patients' Preferences For Characteristics Of Periodontal Disease And Its' Treatment- A Discrete Choice Experiment

    Nov 1, 2016, 00:00

  • Retrospecive Patient Chart Study to Evaluate Real Life Treatment and Event Rate of Patients Surviving Their Myocardial Infarction for at Least 12 Months

    Nov 1, 2016, 00:00

  • Health Technology Assessment Supports Evidence-Based Decision-Making in The Changi General Hospital Marketplace Exercise

    Nov 1, 2016, 00:00

  • Economic Burden of Heart Failure in Chinese Population

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Comprehensive Medication Review (CMR) for Patients Acutely Admitted to Hospital

    Nov 1, 2016, 00:00

  • Comparing Eq-5d-3l And Eq-5d-5l In A General Population

    Nov 1, 2016, 00:00

  • The Economic Burden of Four Heart Conditions in Latin America

    Nov 1, 2016, 00:00

  • “Causal Cascade” Among Outcomes in Non-Small Cell Lung Cancer- Assessing The Direct and Indirect Effects of Symptoms on Health-Related Quality of Life (HRQL) Outcomes

    Nov 1, 2016, 00:00

  • The Impact of Dynamic Transmission Modelling on the Estimated Cost-Effectiveness of Treatment for Chronic Hepatitis C in The United Kingdom

    Nov 1, 2016, 00:00

  • Pharmaceutical Tracking System- An Improvement in Data Accuracy and Uses

    Nov 1, 2016, 00:00

  • What Drives ASMR of Orphan Drugs?

    Nov 1, 2016, 00:00

  • Hospitalization Costs Associated with Crohn's Disease and Ulcerative Colitis in Belgium

    Nov 1, 2016, 00:00

  • Epidemiology of Insulin-Treated Diabetic Patients in French Regions- A Retrospective Cross-Sectional Analysis of National Health Insurance Claims Databases

    Nov 1, 2016, 00:00

  • Quinolones Utilization In Two Tertiary Hospitals In Nigeria; Exploring Drug Use Towards Improved Treatment Outcomes

    Nov 1, 2016, 00:00

  • Level of Informedness about Colorectal Cancer Screening Among Lay Persons

    Nov 1, 2016, 00:00

  • Breast Cancer In Japan- Room For Improved Screening

    Nov 1, 2016, 00:00

  • Modelling the Cost-Effectiveness of Treatment Strategies in Chronic Lymphocytic Leukaemia, Follicular Lymphoma and Multiple Myeloma- A Review and Critical Appraisal of the Published Literature

    Nov 1, 2016, 00:00

  • Bayesian Network of Disease History

    Nov 1, 2016, 00:00

  • Developing A Classification System of Patients Based on Risk Related to Epidemiological and Demographic Variables

    Nov 1, 2016, 00:00

  • Is There an Association Between Diabetic Microvascular Complications and Serum Cholesterol? a Retrospective Analysis among Malaysian Patients with T2DM

    Nov 1, 2016, 00:00
  • «
  • 81
  • 82
  • 83 (current)
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • »